Chronic obstructive pulmonary disease (COPD) consists of two main conditions - emphysema and chronic bronchitis. Emphysema causes damage to air sacs in the lungs, reducing surface area and oxygen intake. Chronic bronchitis involves long-term inflammation of the bronchi, causing coughing and mucus for at least three months per year. Smoking is the primary cause of both conditions. Globally, COPD caused over 3 million deaths in 2015, with over 90% occurring in low and middle-income countries. India has seen COPD cases increase significantly in recent decades.
Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of bronchitis: acute and chronic.
Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of bronchitis: acute and chronic.
Bronchitis is an acute inflammation of the air passages within the lungs. It occurs when the trachea (windpipe) and the large and small bronchi (airways) within the lungs become inflamed because of infection or irritation from certain causes. Homeopathy is the best treatment with no side effects. For further information contact Ph. : +91-265-2250212,
(M) +91 97236 69210
Skype Id : cosmic1021
Email:
drmahavrat@homeopathyhealing.net
chronic obstructive pulmonary disease and its management
chronic obstructive pulmonary disease is a chronic inflammatory lung disease that causes obstructed airflow from the lungs.
COPD typically has a clear cause and a clear path of prevention, and there are ways to slow the progression of the disease.
Pneumonia is an inflammation of the lung parenchyma caused by various microorganisms, including bacteria, mycobacteria, fungi, and viruses.
Pneumonitis is a more general term that describes the inflammatory process in the lung tissue that may predispose and Pneumonia is an inflammation of the lung parenchyma that is caused by a microbial agent.
place the patient at risk for microbial invasion.
Pneumonia is classified into four: community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP), pneumonia in the immunocompromised host, and aspiration pneumonia.
Pneumonia is an inflammatory condition of the lung affecting primarily the small air sacs known as alveoli. Typically symptoms include some combination of productive or dry cough, chest pain, fever, and trouble breathing. Severity is variable.
Pneumonia is usually caused by infection with viruses or bacteria and less commonly by other microorganisms, certain medications and conditions such as autoimmune diseases. Risk factors include cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, diabetes, heart failure, a history of smoking, a poor ability to cough such as following a stroke, and a weak immune system. Diagnosis is often based on the symptoms and physical examination. Chest X-ray, blood tests, and culture of the sputum may help confirm the diagnosis. The disease may be classified by where it was acquired with community, hospital, or health care associated pneumonia.
Vaccines to prevent certain types of pneumonia are available. Other methods of prevention include handwashing and not smoking. Treatment depends on the underlying cause. Pneumonia believed to be due to bacteria is treated with antibiotics. If the pneumonia is severe, the affected person is generally hospitalized. Oxygen therapy may be used if oxygen levels are low.
Pneumonia affects approximately 450 million people globally (7% of the population) and results in about four million deaths per year. Pneumonia was regarded by William Osler in the 19th century as "the captain of the men of death". With the introduction of antibiotics and vaccines in the 20th century, survival improved. Nevertheless, in developing countries, and among the very old, the very young, and the chronically ill, pneumonia remains a leading cause of death. Pneumonia often shortens suffering among those already close to death and has thus been called "the old man's friend"
Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of bronchitis: acute and chronic
Chronic obstructive pulmonary disease, commonly referred to as COPD, is a group of progressive lung diseases. The most common are emphysema and chronic bronchitis. Many people with COPD have both of these conditions.
Emphysema slowly destroys air sacs in your lungs, which interferes with outward air flow. Bronchitis causes inflammation and narrowing of the bronchial tubes, which allows mucus to build up.
The top cause of COPD is tobacco smoking. Long-term exposure to chemical irritants can also lead to COPD. It’s a disease that usually takes a long time to develop.
Diagnosis usually involves imaging tests, blood tests, and lung function tests.
There’s no cure for COPD, but treatment can help ease symptoms, lower the chance of complications, and generally improve quality of life. Medications, supplemental oxygen therapy, and surgery are some forms of treatment.
Untreated, COPD can lead to a faster progression of disease, heart problems, and worsening respiratory infections.
It’s estimated that about 30 million people in the United States have COPD. As many as half are unaware that they have it.
Presented by Mr B.Kalyankumar Msc(N) Dept Of MSN
Bronchitis is an acute inflammation of the air passages within the lungs. It occurs when the trachea (windpipe) and the large and small bronchi (airways) within the lungs become inflamed because of infection or irritation from certain causes. Homeopathy is the best treatment with no side effects. For further information contact Ph. : +91-265-2250212,
(M) +91 97236 69210
Skype Id : cosmic1021
Email:
drmahavrat@homeopathyhealing.net
chronic obstructive pulmonary disease and its management
chronic obstructive pulmonary disease is a chronic inflammatory lung disease that causes obstructed airflow from the lungs.
COPD typically has a clear cause and a clear path of prevention, and there are ways to slow the progression of the disease.
Pneumonia is an inflammation of the lung parenchyma caused by various microorganisms, including bacteria, mycobacteria, fungi, and viruses.
Pneumonitis is a more general term that describes the inflammatory process in the lung tissue that may predispose and Pneumonia is an inflammation of the lung parenchyma that is caused by a microbial agent.
place the patient at risk for microbial invasion.
Pneumonia is classified into four: community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP), pneumonia in the immunocompromised host, and aspiration pneumonia.
Pneumonia is an inflammatory condition of the lung affecting primarily the small air sacs known as alveoli. Typically symptoms include some combination of productive or dry cough, chest pain, fever, and trouble breathing. Severity is variable.
Pneumonia is usually caused by infection with viruses or bacteria and less commonly by other microorganisms, certain medications and conditions such as autoimmune diseases. Risk factors include cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, diabetes, heart failure, a history of smoking, a poor ability to cough such as following a stroke, and a weak immune system. Diagnosis is often based on the symptoms and physical examination. Chest X-ray, blood tests, and culture of the sputum may help confirm the diagnosis. The disease may be classified by where it was acquired with community, hospital, or health care associated pneumonia.
Vaccines to prevent certain types of pneumonia are available. Other methods of prevention include handwashing and not smoking. Treatment depends on the underlying cause. Pneumonia believed to be due to bacteria is treated with antibiotics. If the pneumonia is severe, the affected person is generally hospitalized. Oxygen therapy may be used if oxygen levels are low.
Pneumonia affects approximately 450 million people globally (7% of the population) and results in about four million deaths per year. Pneumonia was regarded by William Osler in the 19th century as "the captain of the men of death". With the introduction of antibiotics and vaccines in the 20th century, survival improved. Nevertheless, in developing countries, and among the very old, the very young, and the chronically ill, pneumonia remains a leading cause of death. Pneumonia often shortens suffering among those already close to death and has thus been called "the old man's friend"
Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of bronchitis: acute and chronic
Chronic obstructive pulmonary disease, commonly referred to as COPD, is a group of progressive lung diseases. The most common are emphysema and chronic bronchitis. Many people with COPD have both of these conditions.
Emphysema slowly destroys air sacs in your lungs, which interferes with outward air flow. Bronchitis causes inflammation and narrowing of the bronchial tubes, which allows mucus to build up.
The top cause of COPD is tobacco smoking. Long-term exposure to chemical irritants can also lead to COPD. It’s a disease that usually takes a long time to develop.
Diagnosis usually involves imaging tests, blood tests, and lung function tests.
There’s no cure for COPD, but treatment can help ease symptoms, lower the chance of complications, and generally improve quality of life. Medications, supplemental oxygen therapy, and surgery are some forms of treatment.
Untreated, COPD can lead to a faster progression of disease, heart problems, and worsening respiratory infections.
It’s estimated that about 30 million people in the United States have COPD. As many as half are unaware that they have it.
Presented by Mr B.Kalyankumar Msc(N) Dept Of MSN
CHRONIC OBUSTRUCTIVE PULMONARY DISEASE POWER POINT.pptxAgbaMakuochi
This describes a whole lot more of what Chronic Obstructive Pulmonary Disease is with their pathophysiology and management both medical and nursing management
Thank you for selecting our 𝐂𝐎𝐏𝐃 PPT
This medical PowerPoint template about 𝐂𝐎𝐏𝐃
You can download our template by visiting our website:
https://www.rxslides.com/product/copd-powerpoint-template
copy and paste this URL into the browser and download the full editable template.
This 𝐂𝐎𝐏𝐃 animated template is designed by RxSlides, a medical professional team covering the following topics about 𝐂𝐎𝐏𝐃
𝐓𝐡𝐞 𝐭𝐞𝐦𝐩𝐥𝐚𝐭𝐞 𝐜𝐨𝐯𝐞𝐫𝐬 𝐭𝐡𝐞 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐭𝐨𝐩𝐢𝐜𝐬
𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧
Chronic obstructive pulmonary disease (𝐂𝐎𝐏𝐃) is a group of lung diseases that cause airflow blockage and breathing-related problems.
𝐩𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞
COPD is more prevalent in developing countries, but it is also a growing problem in developed countries. In the United States, COPD is the third leading cause of death.
Forms of 𝐂𝐎𝐏𝐃
• Chronic bronchitis
• Emphysema
𝐏𝐚𝐭𝐡𝐨𝐩𝐡𝐲𝐬𝐢𝐨𝐥𝐨𝐠𝐲
In normal lungs, air flows freely in and out of the bronchi and alveoli. However, in people with COPD, the airflow is blocked. This can be caused by inflammation of the airways, mucus production, or damage to the air sacs.
𝐑𝐢𝐬𝐤 𝐅𝐚𝐜𝐭𝐨𝐫𝐬
There are several risk factors for COPD, including smoking, air pollution, and genetics. Smoking is the most common risk factor for COPD. Smoking is responsible for about 80% of COPD cases. Air pollution, particularly indoor air pollution from cooking and burning fuels, can also increase the risk of COPD. Genetics can also play a role in COPD. People with a family history of COPD are more likely to develop the disease.
𝐜𝐚𝐮𝐬𝐞𝐬
The main causes of COPD are smoking and air pollution. Smoking damages the lungs and makes it difficult to breathe
𝐒𝐭𝐚𝐠𝐞𝐬
• Stage 1
• Stage 2
• Stage 3
.
𝐒𝐲𝐦𝐩𝐭𝐨𝐦𝐬
The most common symptoms of COPD are:
• Shortness of breath
• Cough
• Wheezing
• Chest tightness
• Fatigue
𝐂𝐨𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬
COPD can lead to several complications, including:
• Anemia
• Right-sided heart failure
• Muscle weakness
• Lung infections
• Bone thinning
• Collapsed lungs
𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐦𝐞𝐭𝐡𝐨𝐝𝐬
COPD is diagnosed with a spirometry test, which measures how much air a person can exhale.
𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐎𝐩𝐭𝐢𝐨𝐧𝐬
There is no cure for COPD, but there are treatments that can help manage the symptoms and slow the progression of the disease. Treatment options include:
• Bronchodilators
• Antibiotics
• Supplemental oxygen
• Vaccination
𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐯𝐞 𝐌𝐞𝐭𝐡𝐨𝐝𝐬
The best way to prevent COPD is to avoid smoking and air pollution. Several lifestyle changes can help reduce the risk of COPD, such as eating a healthy diet and exercising regularly.
Visit our site for more animated templates
𝗵𝘁𝘁𝗽𝘀://𝘄𝘄𝘄.𝗿𝘅𝘀𝗹𝗶𝗱𝗲𝘀.𝗰𝗼𝗺
RxSlides PowerPoint icons and illustrations related to 𝐂𝐎𝐏𝐃 will help you customize the content of this editable presentation according to your content and audience interest.
Explain the pathophysiology behind the signs and symptoms of COP.docxnealwaters20034
Explain the pathophysiology behind the signs and symptoms of COPD.
Chronic Obstructive Pulmonary Disease (COPD) is just as it sounds, a chronic obstruction in the pulmonary function that causes disease. This disease is comprised of two major phenotypes, of which are bronchitis (hypersecretion of mucus and chronic productive cough that occurs consecutively for at least two years with at least a consecutive three-month period each year) (McCance & Huether, 2019) and emphysema (an abnormal permanent enlargement of gas-exchange airways or acini, accompanied by destruction of the alveolar walls without obvious fibrosis (McCance & Huether, 2019). The leading cause of COPD is that of smoking. However, there is another factor that contributes to COPD and that is an inherited mutation in the a1-antitrypsin gene. The development of COPD results from this gene, even in those who do not participate in the consumption of smoke inhalation4. Both emphysema and chronic bronchitis affect ventilation-perfusion mismatch with hypoxemia; however, in chronic bronchitis, bronchial edema is caused by the inspiration of irritants that increases the number and size of mucus glands and goblet cells of the airway (McCance & Huether, 2019). This produces an environment in which mucus cannot be cleared of the airway due to narrowing. Eventually, the continuous production of copious amounts of secretions and narrowed airways lead to an obstruction. In Emphysema, the increases in neutrophils of the airway release protease and elastase that cleave structural collagen and promote tissue breakdown (McCance & Huether, 2019). The introduction of macrophages is also present, which contribute to reduction of surface area regarding gas exchange and loss of cellular apoptosis. When it comes to COPD, the difficulty of expiration is due to the accumulation of copious mucus membranes, loss of elastic recoil (from expansion), and epithelial edema. According to the Centers for Disease Control (CDC), as of 2014, COPD has accounted for 39.1 percent of 100,000 deaths in the United States (CDC, 2018). The CDC also states that, the prevalence of COPD varied amongst states, with Colorado, Hawaii, and Utah exhibiting <4% of cases; Tennesse, West Virginia, Alabama, and Kentucky exhibiting >9%, and states along the lower Mississippi rivers and Ohio exhibit the highest prevalence of COPD (CDC, 2018).
What relationship do you see with Mr. Brown's vital signs – 26 RR, 91% oxygen saturation, temp: 37.8, HR: 93 BP: 150/70
When observing Mr. Brown’s vital signs, his respiration rates are increased at 26. Eupnea (normal breathing) is 8 to 16 beats per minute according to our text (McCance & Huether, 2019). Due to this patients' history of COPD for 10 years, it is safe to say that this patient is breathing heavier due to lack of perfused oxygen. His lungs are working harder at this point to keep him oxygenized. HIs oxygen saturation of 91% exhibits hypoxemia and possibly ‘air trapping’, which can.
What Is COPD? - Allergy & Asthma Associates of Southern CaliforniaPracticeBuilders2
COPD means Chronic Obstructive Pulmonary (Lung) Disease. The key words are “chronic” and “obstructive.” Chronic means that it’s going to be with you a long time. Obstructive means that airflow in the lungs is partly blocked. COPD includes chronic bronchitis, emphysema, or both. Either may compromise lung function. “Chronic bronchitis” is increased cough and mucus production caused by inflammation of the airways. Bronchitis is considered chronic (or long-term) if a person coughs and produces excess mucus most days during three months in a year, for two years in a row. https://www.socalallergy.com/blog/what-is-copd/
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
2. INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung
disease that causes obstructed airflow from the lungs.
It's caused by long-term exposure to irritating gases or particulate matter, most often
from cigarette smoke.
People with COPD are at increased risk of developing heart disease, lung cancer and
a variety of other conditions.
3. INTRODUCTION:-
Emphysema and chronic bronchitis are two conditions that make up chronic
obstructive pulmonary disease (COPD).
Smoking is the leading cause of COPD. Treatment may slow the progression of COPD,
but it can't reverse the damage.
4.
5. DEFINITION:-
Emphysema is a lung condition that causes
shortness of breath.
the air sacs in the lungs (alveoli) are
damaged.
Over time, the inner walls of the air sacs
weaken and rupture — creating larger air
spaces instead of many small ones.
This reduces the surface area of the lungs
and, in turn, the amount of oxygen that
reaches your bloodstream.
6. EMPHYSEMA:-
Emphysema causes dilation of
airspaces by destruction of alveolar
wall, leading to collapse of alveoli
during expiration
Spaces in parenchyma > 1mm = Abnormal
7. TYPES OF EMPHYSEMA
There are four type:
1. Centriacinar
2. Panacinar
3. Paraseptal [Distal acinar]
4. Mixed and unclassified
[Irregular]
8. Prognosis
Mild emphysema- 80% of
patients are alive after 4
years
Moderate emphysema-
60-70% are alive after 4
years
Severe emphysema- 50%
are alive after 4 years
Very severe emphysema-
short life expectancy
9. INCIDENCE
IncidenceEmphysema is present in
approximately 50% of adults who come
to autopsy.
Pulmonary disease was considered to
be responsible for death in 6.5% of
these patients.
10. INCIDENCE
Epidemiology 1.5 million
people are diagnosed with
emphysema
Pulmonary edema afflicts 1%-
2% of the general population.
250,000 cases of pulmonary
emboli a year
12. INTRODUCTION:- BRONCHITIS
Bronchitis is inflammation of the bronchi (large and medium-sized airways) in the
lungs.
Symptoms include coughing up mucus, wheezing, shortness of breath, and chest
discomfort.
Bronchitis is divided into two types:
acute and chronic.
13. CHRONIC
BRONCHITIS:-
Chronic bronchitis is defined as a productive cough that lasts
for three months or more per year for at least two years.
Most people with chronic bronchitis have chronic obstructive
pulmonary disease (COPD). Tobacco smoking is the most
common cause, with a number of other factors such as air
pollution and genetics playing a smaller role.
Treatments include quitting smoking, vaccinations,
rehabilitation, and often inhaled bronchodilators and steroids.
Some people may benefit from long-term oxygen therapy or
lung transplantation.
14. CHRONIC BRONCHITIS:-
Chronic bronchitis is defined as a productive
cough that lasts for three months or more per
year for at least two years.
Most people with chronic bronchitis have
chronic obstructive pulmonary disease
(COPD).
Protracted bacterial bronchitis is defined as a
chronic productive cough with a positive
bronchoalveolar lavage that resolves with
antibiotics.
15.
16. INCIDENCE
The Global Burden of Disease Study reports a prevalence of 251 million
cases of COPD globally in 2016.
Globally, it is estimated that 3.17 million deaths were caused by the
disease in 2015 (that is, 5% of all deaths globally in that year).
More than 90% of COPD deaths occur in low and middleincome countries
17.
18. INCIDENCE
COPD and EMPHYSEMA were responsible for 75·6% and 20·0% of the
chronic respiratory disease DALYs, respectively, in India in 2016.
The number of cases of COPD in India increased from 28·1 million (27·0–
29·2) in 1990 to 55·3 million (53·1–57·6) in 2016, an increase in prevalence
from 3·3% (3·1–3·4) to 4·2% (4·0–4·4).
19. INCIDENCE
The incidence of CHRONIC BRONCHITIS was
2.8 cases per 1,000 population per annum.
Chronic cough and sputum were risk factors
for COPD independent of smoking (OR 1.85,
95% CI 1.17–2.93).
Cape Town, South Africa, has the highest
prevalence, affecting 22.2% of men and 16.7%
of women.